BNP Paribas Bonus Zert AMD 27.06..../ DE000PN5F0X7 /
2024-05-08 9:20:23 AM | Chg.+0.080 | Bid9:55:07 AM | Ask9:55:07 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
83.220EUR | +0.10% | 83.270 Bid Size: 750 |
83.390 Ask Size: 750 |
Advanced Micro Devic... | - USD | 2024-06-27 | Call |
GlobeNewswire
05-07
Optiver Chooses AMD Enterprise Portfolio to Power its Data Center Modernization, Enabling New Era of...
GlobeNewswire
05-07
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
05-06
Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD
GlobeNewswire
05-06
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease ...
GlobeNewswire
05-06
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
05-06
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Prol...
GlobeNewswire
05-03
YieldMax™ ETFs Announces Monthly Distributions on CONY (109.51%), MSTY (103.22%), NFLY (67.74%), SQY...
GlobeNewswire
05-02
Kriya Announces Three Presentations at the 2024 Association for Research in Vision and Ophthalmology...
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire
05-01
Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargard...
GlobeNewswire
05-01
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...
GlobeNewswire
05-01
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024